Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Mercadolibre Inc (MELI) vs Twist Bioscience Corp (TWST) Price & Performance

Mercadolibre IncTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Mercadolibre Inc vs Twist Bioscience Corp — how do they compare? Mercadolibre Inc trades at $1,930.02 (market cap $98.35B), while Twist Bioscience Corp trades at $125.49 (market cap $7.72B). The key difference: Mercadolibre Inc is far larger — about 12.7× Twist Bioscience Corp's market cap, and Mercadolibre Inc is trading nearer its 52-week high, Twist Bioscience Corp nearer its low. Which is the better fit depends on your goals.

MELITWST
Market Cap
$98.35B$7.72B
Sector
Consumer CyclicalHealth
52-Week High
$2.51K$124.88
52-Week Low
$1.55K$24.16
Enterprise Value
$106.00B$7.65B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Mercadolibre Inc

MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.

Read more on MELI

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST